445 related articles for article (PubMed ID: 19211198)
1. Excellent local control from radiation therapy for high-risk neuroblastoma.
Gatcombe HG; Marcus RB; Katzenstein HM; Tighiouart M; Esiashvili N
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1549-54. PubMed ID: 19211198
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma--a surgical perspective.
Losty P; Quinn F; Breatnach F; O'Meara A; Fitzgerald RJ
Eur J Surg Oncol; 1993 Feb; 19(1):33-6. PubMed ID: 8436238
[TBL] [Abstract][Full Text] [Related]
3. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease.
Simon T; Hero B; Bongartz R; Schmidt M; Müller RP; Berthold F
Strahlenther Onkol; 2006 Jul; 182(7):389-94. PubMed ID: 16826357
[TBL] [Abstract][Full Text] [Related]
4. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant.
von Allmen D; Grupp S; Diller L; Marcus K; Ecklund K; Meyer J; Shamberger RC
J Pediatr Surg; 2005 Jun; 40(6):936-41; discussion 941. PubMed ID: 15991174
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma.
Gillis AM; Sutton E; Dewitt KD; Matthay KK; Weinberg V; Fisch BM; Chan A; Gooding C; Daldrup-Link H; Wara WM; Farmer DL; Harrison MR; Haas-Kogan D
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):858-64. PubMed ID: 17517478
[TBL] [Abstract][Full Text] [Related]
6. Localized pelvic neuroblastoma: excellent survival and low morbidity with tailored therapy--the 10-year experience of the French Society of Pediatric Oncology.
Leclair MD; Hartmann O; Heloury Y; Fourcade L; Laprie A; Mechinaud F; Munzer C; Rubie H
J Clin Oncol; 2004 May; 22(9):1689-95. PubMed ID: 15117991
[TBL] [Abstract][Full Text] [Related]
7. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR
Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296
[TBL] [Abstract][Full Text] [Related]
8. [Localized thoracic neuroblastoma: the role of surgery and therapeutic results. Apropos of 40 cases].
Rubie H; Hartmann O; Giron A; Lemoine G; Guitard J; Robert A; Lemerle J
Chir Pediatr; 1990; 31(3):146-51. PubMed ID: 2081361
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative electron irradiation in the management of pediatric malignancies.
Schomberg PJ; Gunderson LL; Moir CR; Gilchrist GS; Smithson WA
Cancer; 1997 Jun; 79(11):2251-6. PubMed ID: 9179074
[TBL] [Abstract][Full Text] [Related]
10. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
[TBL] [Abstract][Full Text] [Related]
11. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic large cell neuroblastoma.
Abramowsky CR; Katzenstein HM; Alvarado CS; Shehata BM
Pediatr Dev Pathol; 2009; 12(1):1-5. PubMed ID: 18397155
[TBL] [Abstract][Full Text] [Related]
13. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
14. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
15. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
Canete A; Gerrard M; Rubie H; Castel V; Di Cataldo A; Munzer C; Ladenstein R; Brichard B; Bermúdez JD; Couturier J; de Bernardi B; Pearson AJ; Michon J
J Clin Oncol; 2009 Mar; 27(7):1014-9. PubMed ID: 19171715
[TBL] [Abstract][Full Text] [Related]
16. Excellent local control and survival after intraoperative and external beam radiotherapy for pediatric solid tumors: long-term follow-up of the Mayo Clinic experience.
Stauder MC; Laack NN; Moir CR; Schomberg PJ
J Pediatr Hematol Oncol; 2011 Jul; 33(5):350-5. PubMed ID: 21602722
[TBL] [Abstract][Full Text] [Related]
17. Local control, survival, and operative morbidity and mortality after re-resection, and intraoperative radiation therapy for recurrent or persistent primary high-risk neuroblastoma.
Rich BS; McEvoy MP; LaQuaglia MP; Wolden SL
J Pediatr Surg; 2011 Jan; 46(1):97-102. PubMed ID: 21238648
[TBL] [Abstract][Full Text] [Related]
18. A single institution experience of combined modality management of extra skeletal Ewings sarcoma.
Venkitaraman R; George MK; Ramanan SG; Sagar TG
World J Surg Oncol; 2007 Jan; 5():3. PubMed ID: 17217537
[TBL] [Abstract][Full Text] [Related]
19. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
Paulino AC; Mayr NA; Simon JH; Buatti JM
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
[TBL] [Abstract][Full Text] [Related]
20. Patterns of local recurrence after intraoperative radiotherapy for advanced neuroblastoma.
Kunieda E; Hirobe S; Kaneko T; Nagaoka T; Kamagata S; Nishimura G
Jpn J Clin Oncol; 2008 Aug; 38(8):562-6. PubMed ID: 18667476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
